Early cancer tumor marker

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01)

Patent

CA 2384579

MK (midkine) was found to rise in the blood or urine of patients with various types of cancers at early stage. Based on this finding, a method for detecting early cancer, comprising the step of measuring MK in blood or urine was completed.

On a découvert que la Midkine (MK) est présente au stade précoce dans le sang ou l'urine de patients atteints de divers types de cancer. A partir de cette découverte on a élaboré un procédé de détection des cancers au stade précoce qui consiste à mesurer le taux de MK dans le sang ou les urines.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Early cancer tumor marker does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Early cancer tumor marker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Early cancer tumor marker will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1655065

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.